ESR1 and breast carcinoma: In comparing groups of very young women, however, Collins and colleagues [12] did not find significant differences in histological features or the expression of ER, PgR and HER2 between patients aged ≤30 (n = 47), 31 to 35 (n = 111) and 36 to 40 (n = 241) years at breast cancer diagnosis in a prospective study, except for a trend of higher tumor necrosis in the youngest group (32% versus 14% and 21%, P = 0.06).